Acute myocardial infarction and subacute stent thrombosis associated with cabazitaxel: a case report
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, cilt.34, sa.3, ss.418-421, 2012 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 34 Sayı: 3
- Basım Tarihi: 2012
- Doi Numarası: 10.1007/s11096-012-9629-z
- Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.418-421
- Anahtar Kelimeler: Acute myocardial infarction, Cabazitaxel, Cancer, Cardiotoxicity, RESISTANT PROSTATE-CANCER, DOCETAXEL, MITOXANTRONE, PREDNISONE, CARDIOTOXICITY
- Akdeniz Üniversitesi Adresli: Evet
Özet
Case Although newer cancer treatments and supportive care treatments have led to vast improvements in the management of complications associated with cancer treatment, sometimes they might cause serious side effects such as coronary artery disease, myocardial infarction and heart failure. These complications may occur any time during or after chemotherapeutics. In this report we present a patient with prostate cancer who experienced myocardial infarction and stent thrombosis probably caused by cabazitaxel -a new chemotherapeutic agent- administration. Conclusion Cardiologists and oncologists should take into consideration the cardiac side effects of new chemotherapeutic agents with the aim of maximizing both quality of life and survival.